Ledger.Open graph →
SEC Form D · filed January 8, 2019

Tiburio Therapeutics Inc

Offering
$31.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

James G. Mcarthur · Cambridge, MAExecDavid K. Mott · Cambridge, MADirectorMette K. Agger · Cambridge, MADirectorSandip K. Agarwala · Cambridge, MADirectorChristoph M. Adams · Cambridge, MAExec · DirectorSara K. Nayeem · Cambridge, MADirectorAbraham N. Ceesay · Cambridge, MAExecJohn Santini · MINNEAPOLIS, MNDirectorTimothy M. Alles · Newtown Square, PADirectorMichael R. Markunas · Los Angeles, CAExecSam Ellis · Grand Cayman, Cayman IslandsExec · DirectorMelissa T. Heim · Portland, ORDirectorMichael A. Stolper · Newtown Square, PADirectorFrances E. Tuite · Chicago, ILDirectorJoshua J. Feldman · New York, NYDirectorDavid A. Frosh · Irvine, CADirectorStephen P. Couig · Irvine, CAExecJonathan Potter · Overland Park, KSExec · DirectorChristopher Sirani · Rancho Santa Fe, CADirectorAbraham N. Ceesay · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗